#United States #White Plains #Retia Medical #Argos Infinity #Bruce Brandes

Retia Medical Welcomes Bruce Brandes to Its Strategic Advisory Board

Retia Medical, a leader in cardiovascular intelligence software, has announced the strategic appointment of Bruce Brandes to its Advisory Board. This development comes at a pivotal time as the company expands the commercial reach of its innovative product, Argos Infinity™. This software not only provides continuous hemodynamic monitoring but is also designed to leverage existing hospital infrastructure, making it easier for clinicians to gain crucial cardiovascular insights.

Bruce Brandes: A Game-Changer in Digital Health

Bruce Brandes brings an impressive portfolio to Retia Medical, including extensive experience in digital health as the former President of care.ai and the current CEO of Mindyra. His multifaceted expertise in healthcare technology will greatly benefit Retia as it seeks to better position itself in the rapidly evolving healthcare landscape.

“What Retia has accomplished so far is commendable,” Brandes notes. “The clinical evidence and FDA clearance for Argos Infinity have set the stage for a paradigm shift in hemodynamic monitoring. I believe in the potential of their non-invasive algorithms to cater to broader patient populations.”

Prior to his new mandate at Retia, Brandes has had a storied career, including pivotal roles at Livongo and Teladoc Health, where he played an instrumental role in integrating various health platforms. His insights into healthcare commercialization and digital technology signal an exciting new chapter for Retia Medical.

Argos Infinity™: A Leap Forward in Hemodynamic Monitoring

Retia’s flagship product, Argos Infinity™, recently received FDA 510(k) clearance and has shown a remarkable growth trajectory. Just two years since its inception, the company has managed to increase annual revenue by sixfold, demonstrating robust demand and effectiveness.

The innovative platform transforms routine physiological monitoring data into actionable intelligence, enabling clinicians to detect, diagnose, and manage cardiovascular issues more effectively. This capability not only helps improve patient outcomes but also positions Retia at the forefront of cardiovascular technology solutions.

As Brandes joins the Advisory Board, he will be focusing on capitalizing on this momentum to deepen the commercial and clinical impacts of Argos Infinity™. His goal will be to help the company navigate its international expansion and optimize its algorithms, making critical cardiovascular insights accessible to more healthcare providers.

Future Directions

With Brandes on board, Retia Medical is poised for significant growth. He adds, “I look forward to collaborating with the team as we aim to enhance the value of Argos Infinity™ in clinical settings.” As the healthcare landscape continues to shift towards technology-driven solutions, Retia Medical appears well-prepared to meet the demands of healthcare providers and patients alike.

In conclusion, the strategic hiring of Bruce Brandes marks not just an addition to the team, but a strong commitment to pushing the boundaries of cardiovascular care through innovation. As the company continues to grow, stakeholders can expect exciting advancements that could redefine cardiovascular monitoring practices in healthcare facilities across the country and beyond.